DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Schulz H, Rehwald U, Morschhauser F. et al.
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Blood 2008;
111: 109-111
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.